l-asparaginase monotherapy as an encouraging approach towards acute fulminant chronic active Epstein-Barr virus infection

Br J Haematol. 2024 Oct;205(4):1610-1614. doi: 10.1111/bjh.19652. Epub 2024 Jul 19.

Authors

Yoshiki Furukawa¹, Jun Ando^{1

2}, Midori Ishii¹, Shintaro Kinoshita¹, Ayaka Goto¹, Kota Tachibana², Yoko Azusawa², Takao Kato³, Norihide Izumi¹, Erina Hosoya¹, Ayana Uchimura¹, Tadaaki Inano¹, Shuichi Shirane¹, Yutaka Tsukune¹, Tomoiku Takaku¹, Yasuharu Hamano¹, Miki Ando¹

Affiliations

¹ Department of Hematology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan.
² Division of Cell Therapy & Blood Transfusion Medicine, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan.
³ Department of Cardiovascular Biology and Medicine, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan.

PMID: 39030904
DOI: 10.1111/bjh.19652

No abstract available

Publication types

Letter